Immunoneoadjuvant therapy with immune checkpoint inhibitors of gastric cancer: an emerging exemplification

This article reviews the progress in the use of ICI monotherapy and in combination with alternative therapies for the treatment of gastric cancer to aid in the development of gastric cancer immunoneoadjuvant therapy and improve the overall therapeutic benefit.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research